BIO · Company research
Bio-Rad Laboratories, Inc.Class A (BIO): Stock News & Events
Recent company-linked news records available in the database.
RESEARCH CONTEXT
Understand the numbers
Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.
29records availableHealthcare
Stock News & Events data
Database-backed records only
| title | summary | url | source | published at | sentiment | sentiment score | relevance score |
|---|---|---|---|---|---|---|---|
| Braveheart Bio, Inc. (NASDAQ:BRVE) Shares Shorted: Short Interest Up 67.8% in September - MarketBeat | Braveheart Bio, Inc. (NASDAQ:BRVE) Shares Shorted: Short Interest Up 67.8% in September MarketBeat | View source ↗ | MarketBeat | Oct 16, 2026 | neutral | 0 | 0.6 |
| Belite Bio, Inc (BLTE) Stock Price, News, Quote & History - Yahoo! Finance Canada | Belite Bio, Inc (BLTE) Stock Price, News, Quote & History Yahoo! Finance Canada | View source ↗ | Yahoo! Finance Canada | Oct 16, 2026 | neutral | 0 | 0.6 |
| Gossamer Bio files FDA application. Gossamer Bio stock sits at USD 54.3 million market value. - ad-hoc-news.de | Gossamer Bio files FDA application. Gossamer Bio stock sits at USD 54.3 million market value. ad-hoc-news.de | View source ↗ | ad-hoc-news.de | Oct 16, 2026 | neutral | 0 | 0.6 |
| At TRex Bio (TRXB), preferred shares converted into 1,167,930 common shares at the IPO closing. - Stock Titan | At TRex Bio (TRXB), preferred shares converted into 1,167,930 common shares at the IPO closing. Stock Titan | View source ↗ | Stock Titan | Oct 15, 2026 | neutral | 0 | 0.6 |
| Nuvation Bio Inc. (NUVB) Stock Price, News, Quote & History - Yahoo! Finance Canada | Nuvation Bio Inc. (NUVB) Stock Price, News, Quote & History Yahoo! Finance Canada | View source ↗ | Yahoo! Finance Canada | Oct 15, 2026 | neutral | 0 | 0.6 |
| Belite Bio stock price target maintained at $245 by H.C. Wainwright - Investing.com | Belite Bio stock price target maintained at $245 by H.C. Wainwright Investing.com | View source ↗ | Investing.com | Oct 15, 2026 | neutral | 0 | 0.6 |
| Report from Hong Kong: what the Greater Bay Area offers Nordic life science - Biostock | Report from Hong Kong: what the Greater Bay Area offers Nordic life science Biostock | View source ↗ | Biostock | Oct 15, 2026 | neutral | 0 | 0.6 |
| Nuvation Bio Inc. (NUVB) stock price, news, quote and history - Yahoo Finance UK | Nuvation Bio Inc. (NUVB) stock price, news, quote and history Yahoo Finance UK | View source ↗ | Yahoo Finance UK | Oct 15, 2026 | neutral | 0 | 0.6 |
| A 2 p.m. Pacific call is scheduled to discuss Bio-Rad's third-quarter results Nov. 4. - Stock Titan | A 2 p.m. Pacific call is scheduled to discuss Bio-Rad's third-quarter results Nov. 4. Stock Titan | View source ↗ | Stock Titan | Oct 14, 2026 | neutral | 0 | 0.6 |
| symbol__ Stock Quote Price and Forecast - CNN | symbol__ Stock Quote Price and Forecast CNN | View source ↗ | CNN | Oct 13, 2026 | neutral | 0 | 0.6 |
| ENTX: Entera Bio Ltd Latest Stock Price, Analysis, News and Trading Ideas - Stocktwits | ENTX: Entera Bio Ltd Latest Stock Price, Analysis, News and Trading Ideas Stocktwits | View source ↗ | Stocktwits | Oct 13, 2026 | neutral | 0 | 0.6 |
| Bio Key International Offers Up To 1,236,668 Shares Of Common Stock By The Selling Stockholder - TradingView | Bio Key International Offers Up To 1,236,668 Shares Of Common Stock By The Selling Stockholder TradingView | View source ↗ | TradingView | Oct 9, 2026 | neutral | 0 | 0.6 |
| A passive fund reports more than 5% ownership of Q32 Bio (QTTB). - Stock Titan | A passive fund reports more than 5% ownership of Q32 Bio (QTTB). Stock Titan | View source ↗ | Stock Titan | Oct 9, 2026 | neutral | 0 | 0.6 |
| TRex Bio Shares Trade Lower in Nasdaq Debut - marketscreener.com | TRex Bio Shares Trade Lower in Nasdaq Debut marketscreener.com | View source ↗ | marketscreener.com | Oct 9, 2026 | neutral | 0 | 0.6 |
| Report from BioJapan: Nordic biotech on the long game in Japan - Biostock | Report from BioJapan: Nordic biotech on the long game in Japan Biostock | View source ↗ | Biostock | Oct 9, 2026 | neutral | 0 | 0.6 |
| A potential radiation drug could be absorbed through the mouth instead of injected. - Stock Titan | A potential radiation drug could be absorbed through the mouth instead of injected. Stock Titan | View source ↗ | Stock Titan | Oct 9, 2026 | neutral | 0 | 0.6 |
| TRex Bio prices $117M IPO to support immune drug work - BioPharma Dive | TRex Bio prices $117M IPO to support immune drug work BioPharma Dive | View source ↗ | BioPharma Dive | Oct 9, 2026 | neutral | 0 | 0.6 |
| Palisade Bio stock initiated at Outperform by Raymond James - Investing.com Nigeria | Palisade Bio stock initiated at Outperform by Raymond James Investing.com Nigeria | View source ↗ | Investing.com Nigeria | Oct 9, 2026 | neutral | 0 | 0.6 |
| YD Bio Limited Ordinary Shares (YDES) Stock Price: Oct 7 Close $5.88 - Gotrade | YD Bio Limited Ordinary Shares (YDES) Stock Price: Oct 7 Close $5.88 Gotrade | View source ↗ | Gotrade | Oct 8, 2026 | neutral | 0 | 0.6 |
| Palisade Bio, Inc. (PALI) Stock Price, News, Quote & History - Yahoo! Finance Canada | Palisade Bio, Inc. (PALI) Stock Price, News, Quote & History Yahoo! Finance Canada | View source ↗ | Yahoo! Finance Canada | Oct 7, 2026 | neutral | 0 | 0.6 |
| Bio-Rad Laboratories, Inc. (BIO) stock price, news, quote and history - Yahoo Finance Singapore | Bio-Rad Laboratories, Inc. (BIO) stock price, news, quote and history Yahoo Finance Singapore | View source ↗ | Yahoo Finance Singapore | Oct 7, 2026 | neutral | 0 | 0.6 |
| Bio-Rad Laboratories, Inc. (BIO) Stock Price, News, Quote & History - Yahoo! Finance Canada | Bio-Rad Laboratories, Inc. (BIO) Stock Price, News, Quote & History Yahoo! Finance Canada | View source ↗ | Yahoo! Finance Canada | Oct 7, 2026 | neutral | 0 | 0.6 |
| Neogen (NEOG) Q1 Earnings and Revenues Beat Estimates | Neogen reported quarterly earnings of $0.08 per share, beating consensus estimates of $0.05 and marking a 60% earnings surprise. The company also exceeded revenue expectations with $222.8 million, up from $209.19 million year-over-year. Despite strong performance, Neogen's Medical-Products industry ranks in the bottom 35% of Zacks industries. The stock has gained 86.1% year-to-date and holds a Zacks Rank #2 (Buy) rating. | View source ↗ | Zacks Investment Research | Oct 6, 2026 | bullish | 0.333 | 1 |
| H.C. Wainwright reiterates Korro Bio stock rating on trial dosing - Investing.com | H.C. Wainwright reiterates Korro Bio stock rating on trial dosing Investing.com | View source ↗ | Investing.com | Oct 6, 2026 | neutral | 0 | 0.6 |
| Global Microfluidics Market by Product Type, Application, End User, and Region, 2026-2036 | $48.04 Billion Opportunity Driven by Point-of-Care Diagnostics and Automation | The global microfluidics market is projected to grow from $21.58 billion in 2025 to $48.04 billion by 2036, with a CAGR of 7.49%. Growth is driven by rising demand for rapid diagnostics, point-of-care testing, genomic analysis, and automated workflows. Microfluidic consumables dominate with 66.7% market share, while Asia-Pacific is expected to register the highest regional growth at 8.72% CAGR. | View source ↗ | GlobeNewswire Inc. | Oct 6, 2026 | bullish | 1 | 1 |
| Global Microfluidics Market by Product Type, Application, End User, and Region, 2026-2036 | $48.04 Billion Opportunity Driven by Point-of-Care Diagnostics and Automation | The global microfluidics market is projected to grow from $21.58 billion in 2025 to $48.04 billion by 2036, with a CAGR of 7.49%. Growth is driven by rising demand for rapid diagnostics, point-of-care testing, genomic analysis, and automated workflows. Microfluidic consumables dominate with 66.7% market share, while Asia-Pacific is expected to register the highest regional growth at 8.72% CAGR. | View source ↗ | GlobeNewswire Inc. | Oct 6, 2026 | bullish | 1 | 1 |
| Europe Point of Care Diagnostics Market Size and Forecast, 2021 - 2031 | Market to Reach US$21.4 Billion by 2031 as Rapid Testing and Molecular Innovation Drive 13.4% CAGR | Europe's Point of Care (POC) Diagnostics Market is projected to grow from US$8.9 billion in 2024 to US$21.4 billion by 2031, with a 13.4% CAGR driven by rapid testing innovation, molecular diagnostics advancement, and increasing prevalence of infectious and chronic diseases. Germany leads the regional market, supported by strong healthcare infrastructure and public health initiatives. Key players include Siemens AG, Abbott Laboratories, Roche, bioMerieux, Bio-Rad, QIAGEN, Nova Biomedical, Polymer Technology Systems, and Danaher Corp. | View source ↗ | GlobeNewswire Inc. | Oct 5, 2026 | bullish | 1 | 1 |
| Immunogenomics Market Size, Share, Trends, and Growth Forecast, 2026-2033 | NGS and Personalized Medicine Drive Market Toward USD 9.82 Billion at 5.97% CAGR | The global immunogenomics market is projected to grow from USD 6.32 billion in 2025 to USD 9.82 billion by 2033, expanding at a CAGR of 5.97%. Growth is driven by advancements in next-generation sequencing technologies, increasing demand for personalized medicine, and rising prevalence of immune-related disorders. Key applications include oncology, infectious disease research, vaccine development, and autoimmune disorder studies, with adoption across hospitals, diagnostic laboratories, pharmaceutical companies, and academic institutions. | View source ↗ | GlobeNewswire Inc. | Oct 5, 2026 | bullish | 1 | 1 |
| Magnetic Beads Market - Global Forecast and Growth Opportunities, 2026-2032 | Automation, Genomics, and Molecular Diagnostics Drive 7.91% CAGR Toward USD 6.18 Billion | The global magnetic beads market is projected to grow from USD 3.90 billion in 2026 to USD 6.18 billion by 2032, driven by automation, molecular diagnostics, genomics, and bioprocessing applications. Key growth drivers include adoption of automated magnetic separation platforms, advanced surface chemistries, AI-enabled workflow optimization, and expanding diagnostics capacity across regions. Strategic priorities for industry leaders include developing application-specific chemistries, strengthening supply-chain resilience, and leveraging AI analytics. | View source ↗ | GlobeNewswire Inc. | Oct 5, 2026 | bullish | 1 | 1 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.